BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2904317)

  • 21. [Effectiveness and safety of lansoprazole in the treatment of peptic ulcer].
    Ramón Nogueira J; Esquivel Ayanegui F; Esquivel Rodríguez F; Sáenz V; Santoyo R
    Rev Gastroenterol Mex; 1996; 61(4):314-9. PubMed ID: 9072782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment effectiveness in destructive pulmonary tuberculosis and gastric and duodenal peptic ulcer].
    Petrenko VM
    Sov Med; 1980; (4):111-3. PubMed ID: 7384869
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of gastric ulcer with famotidine. (Multicenter study)].
    Bernal Sahagún F; Barinagarrementería AR; Barrera Ríos L; Briseño Velazco S; Casillas Romo A; Corral Medina A; De la Torre Bravo A; Díaz de León E; Díaz Seoane R; Gallo Reynoso S
    Rev Gastroenterol Mex; 1989; 54(1):7-11. PubMed ID: 2667079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of a combination of colloidal bismuth and pirenzepine in duodenal ulcer in non-responders to anti-H2 receptors].
    Manca A; Ferraris R; Ghezzo L; Asnaghi G; Ferro GF
    Minerva Dietol Gastroenterol; 1988; 34(2):135-8. PubMed ID: 3173756
    [No Abstract]   [Full Text] [Related]  

  • 25. Famotidine has no significant effect on gonadal function in man.
    Savarino V; Giusti M; Scalabrini P; Bessarione D; Magnolia MR; Percario G; Celle G
    Gastroenterol Clin Biol; 1988 Jan; 12(1):19-22. PubMed ID: 3127266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current directions in the treatment of gastric and duodenal ulcers].
    Fellus R
    Dakar Med; 1988; 33(1-4):42-4. PubMed ID: 2908566
    [No Abstract]   [Full Text] [Related]  

  • 27. [Nizatidine].
    Romero M; Franzosi MG
    Medicina (Firenze); 1989; 9(1):93-6. PubMed ID: 2567957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?
    Geus WP
    Scand J Gastroenterol Suppl; 2000; (232):10-20. PubMed ID: 11232484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Strong inhibition of gastric acid secretion: when is it justifiable?].
    Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A
    G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease.
    Kamada T; Hata J; Kusunoki H; Sugiu K; Ito M; Tanaka S; Kawamura Y; Chayama K; Haruma K
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():99-104. PubMed ID: 15943855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Famotidine once-a-day in the therapy of acute, benign gastric ulcer: a worldwide experience.
    Simon B; Müller P; Dammann HG
    J Clin Gastroenterol; 1987; 9 Suppl 2():19-22. PubMed ID: 2887614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Famotidine in the short and long term treatment of duodenal ulcer: clinical and physiopathologic study].
    Vio A; Pasqualetti P; Gottardello L; Grassi SA; Vianello F; Dal Santo L; Tessaro P; Di Mario F; Naccarato R
    G Clin Med; 1989 Mar; 70(3):195-201. PubMed ID: 2759390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.
    Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Uchida T; Fujiwara Y; Arakawa T
    Int J Clin Pharmacol Res; 2005; 25(4):187-94. PubMed ID: 16402635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quamatel application in three-drug eradication therapy of duodenal ulcer and gastroduodenal ulcerations associated with helicobacter pylori infection].
    Mansurova FKh; Kadyrov DM; Odinaev RI; Ishankulova DM
    Klin Med (Mosk); 2000; 78(6):53-6. PubMed ID: 10900873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of 20 mg/day famotidine in the treatment of acute gastric mucosal lesions.
    Miwa T
    J Int Med Res; 1989; 17 Suppl 1():41A-47A. PubMed ID: 2656335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A single evening dose of 300 mg ranitidine in the treatment of acute attacks of gastric and duodenal ulcers. Evaluation of 1,208 patients].
    Bories P; Tournade JM; Alberola B; Pappo M
    Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):227-32. PubMed ID: 3061358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience.
    Bianchi Porro G
    Digestion; 1985; 32 Suppl 1():62-9. PubMed ID: 2866137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Healing-promoting action of rhinax with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
    Dhuley JN
    Hindustan Antibiot Bull; 2003 Feb-2004 Nov; 45-46(1-4):34-40. PubMed ID: 16281827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Famotidine: proven once-a-day treatment for gastric ulcer.
    Dammann HG; Walter TA; Hentschel E; Muller P; Simon B
    Scand J Gastroenterol Suppl; 1987; 134():29-33. PubMed ID: 3310200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.